Human Intelligence

Stanford-backed AI company focused on modeling human physiology and biological systems.

Funding & Positioning

• April 25, 2026: Stanford professor James Zou raising at a $1B valuation for Human Intelligence, an AI company modeling human physiology and biological systems. The fundraise is significant less as a single round and more as a marker for where vertical-AI capital is flowing: code-gen and customer-support agents dominated the narrative a year ago; physiology, drug discovery, and protein function are the dominant sectors today. (2026-04-25-AI-Digest)

Strategic Context

Human Intelligence’s $1B valuation pre-broad-revenue is a datapoint in the broader vertical-AI capital thesis: domains where foundation-model techniques meet domain-specific data moats and the buyer is regulated (healthcare, pharma) are attracting venture capital at frontier-model scale multiples. The competitive cohort includes Isomorphic Labs and Recursion, plus the academic-spinout pattern that produced AlphaFold-derived efforts.

Related Digests

• 2026-04-25-AI-Digest — Human Intelligence $1B valuation for AI physiology models